Diego Vergani
About
In The Last Decade
Diego Vergani
413 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hepatology 12.4k
- Epidemiology 11.2k
- Surgery 4.1k
- Immunology 4.0k
- Rheumatology 3.0k
Countries citing papers authored by Diego Vergani
This map shows the geographic impact of Diego Vergani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Vergani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Vergani more than expected).
Fields of papers citing papers by Diego Vergani
This network shows the impact of papers produced by Diego Vergani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Vergani. The network helps show where Diego Vergani may publish in the future.
Co-authorship network of co-authors of Diego Vergani
This figure shows the co-authorship network connecting the top 25 collaborators of Diego Vergani. A scholar is included among the top collaborators of Diego Vergani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Vergani. Diego Vergani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 62 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | B-CELL EPITOPE MAPPING OF ANTI-RO-52 RESPONSES IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS | 1 |
| 7 | 1 | |
| 8 | GLUTATHIONINE S-TRANSFERASE THETA 1 (GSTT1) MISMATCH DOES NOT ACCOUNT FOR POST LIVER TRANSPLANT DE NOVO AUTOIMMUNE HEPATITIS | 5 |
| 9 | 1 | |
| 10 | Immunodominant HLA-A2 restricted CD8 T cell epitope in autoimmune hepatitis type 2. | 2 |
| 11 | Non-alcoholic fatty liver disease in children | 5 |
| 12 | Autoantibodies to soluble liver antigen/UGA suppressor tRNA-associated antigenic protein are specific to autoimmune liver disease. | 3 |
| 13 | Cross-reactivity to lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis. | 7 |
| 14 | Basic and clinical immunology | 40 |
| 15 | 69 | |
| 16 | Treatment with prednisolone suppresses interleukin 1 soluble interleukin 2 receptor and immunoglobulin g in cystic fibrosis patients | 1 |
| 17 | 15 | |
| 18 | 50 | |
| 19 | 44 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.